Hyoscine Butylbromide is a quaternary ammonium anticholinergic agent widely used to treat abdominal pain, bladder spasms, and for symptom management in palliative care. This compound acts by blocking muscarinic… Read more
![Chemical structure of (1R,2R,4S,5S,7s)-9-Butyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 3-hydroxy-2-phenylpropanoate Hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2R4S5S7s-9-Butyl-3-oxa-9-azatricyclo3.3.1.024nonan-7-yl-3-hydroxy-2-phenylpropanoate-Hydrochloride.png&w=3840&q=75)
![Chemical structure of (1R,2R,5S,7S)-7-(((S)-3-Hydroxy-2-phenylpropanoyl)oxy)-9-methyl-9-propyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2R5S7S-7-S-3-Hydroxy-2-phenylpropanoyloxy-9-methyl-9-propyl-3-oxa-9-azatricyclo3.3.1.024nonan-9-ium-Bromide.png&w=3840&q=75)












Hyoscine Butylbromide is a quaternary ammonium anticholinergic agent widely used to treat abdominal pain, bladder spasms, and for symptom management in palliative care. This compound acts by blocking muscarinic acetylcholine receptors, thereby reducing smooth muscle contractions and glandular secretions. In pharmaceutical analysis, the related compounds in this category—including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled standards—are essential for robust quality control. Analytical laboratories rely on these reference standards for comprehensive impurity profiling, method validation, and stability studies to ensure regulatory compliance and therapeutic efficacy. By utilizing these well-characterized materials, researchers can accurately identify, quantify, and monitor process-related impurities or synthetic intermediates throughout the drug development lifecycle, ensuring the consistency and safety of the final pharmaceutical product.